Nanoco is using expertise in nanomaterials for use in displays and lighting to develop better ways of detecting and treating deadly forms of cancer.
A University of Manchester spin-out is developing nanomaterials known for their use in lighting and solar energy into new fluorescent biomarkers that could detect and improve treatment of some of the deadliest forms of cancer.
Nanoco Group PLC (LON:NANO) leads the world in the research, development and large-scale manufacture of heavy metal-free nanomaterials for use in displays, lighting, vertical farming, solar energy and bio-imaging.